Related Experiment Video
Updated: May 10, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
Published on: June 30, 2023
Ursolic acid promotes cancer cell death by inducing Atg5-dependent autophagy
Shuilong Leng1, Yanli Hao, Daobing Du
1Department of Human Anatomy, Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
Abstract:
Ursolic acid (UA) has been reported to possess anticancer activities. Although some of the anticancer activities of UA have been explained by its apoptosis-inducing properties, the mechanisms underlying its anticancer actions are largely unknown. We have found that UA-activated autophagy induced cytotoxicity and reduced tumor growth of cervical cancer cells TC-1 in a concentration-dependent manner. UA did not induce apoptosis of TC-1 cells in vitro as determined by annexin V/propidium iodide staining, DNA fragmentation, and Western blot analysis of the apoptosis-related proteins. We found that UA increased punctate staining of light chain 3 (LC3), which is an autophagy marker. LC3II, the processed form of LC3I which is formed during the formation of double membranes, was induced by UA treatment. These results were further confirmed by transmission electron microscopy. Wortmannin, an inhibitor of autophagy, and a small interfering RNA (siRNA) for autophagy-related genes (Atg5) reduced LC3II and simultaneously increased the survival of TC-1 cells treated with UA. We also found that LC3II was significantly reduced and that survival was increased in Atg5-/- mouse embryonic fibroblast (MEF) cells compared to Atg5+/+ MEF cells under UA treatment. However, silencing BECN1 by siRNA affected neither the expression of LC3II nor the survival of TC-1 cells under UA treatment. These results suggest that autophagy is a major mechanism by which UA kills TC-1 cells. It is Atg5 rather than BECN1 that plays a crucial role in UA-induced autophagic cell death in TC-1 cells. The activation of autophagy by UA may become a potential cancer therapeutic strategy complementing the apoptosis-based therapies. Furthermore, regulation of Atg5 may improve the efficacy of UA in cancer treatment.
Insights
Ursolic acid (UA) triggers autophagy, a cell-death process, in cervical cancer cells, reducing tumor growth. This autophagy, mediated by Atg5, offers a new therapeutic strategy for cancer treatment.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Ursolic acid (UA) exhibits anticancer properties, but its mechanisms remain unclear.
- While some UA anticancer effects are linked to apoptosis, this study explores alternative pathways.
- Cervical cancer remains a significant health concern, necessitating novel therapeutic approaches.
Purpose of the Study:
- To investigate the role of autophagy in the anticancer effects of ursolic acid (UA) on TC-1 cervical cancer cells.
- To determine whether UA-induced cell death occurs via apoptosis or autophagy.
- To identify key autophagy-related genes involved in UA's mechanism of action.
Main Methods:
- TC-1 cells and mouse embryonic fibroblast (MEF) cells (Atg5+/+ and Atg5-/-) were treated with UA.
- Apoptosis was assessed using Annexin V/propidium iodide staining, DNA fragmentation, and Western blotting.
- Autophagy was evaluated by monitoring LC3 (microtubule-associated protein 1A/1B-light chain 3) puncta, LC3II levels, and transmission electron microscopy.
- Inhibitors like wortmannin and gene silencing (siRNA for Atg5 and BECN1) were employed to modulate autophagy pathways.
Main Results:
- UA treatment induced autophagy, evidenced by increased LC3 puncta and LC3II levels in TC-1 cells, without inducing apoptosis.
- Autophagy inhibition (wortmannin or Atg5 siRNA) reduced UA-induced cytotoxicity and LC3II expression.
- MEF cells lacking Atg5 (Atg5-/-) showed significantly reduced LC3II and increased survival upon UA treatment compared to wild-type MEF cells.
- Silencing BECN1 did not affect UA-induced autophagy or cell survival.
Conclusions:
- Autophagy, specifically dependent on Atg5, is a primary mechanism for UA-induced cell death in TC-1 cervical cancer cells.
- UA-induced autophagic cell death presents a potential therapeutic strategy, distinct from apoptosis-based treatments.
- Targeting Atg5 may enhance the efficacy of ursolic acid in cancer therapy.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
